DropGenie Raises Seed+ Round to Launch Miniaturized Gene Editing Platform
DropGenie has closed a Seed+ financing round led by Skeleton Key with participation from Merck Global Health Innovation Fund and CQDM to support the commercial launch of its first gene editing product.